Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: MIZAR THERAPEUTICS INC.
Awarding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Funding agency: National Aeronautics and Space Administration / National Aeronautics and Space Administration
Period of performance: 2024-08-07 to 2025-02-06
Current total value of award: $155536
Description: FY24 SBIR PHASE I- MIZAR S/TAR HIGH-THROUGHPUT PLATFORM FOR IDENTIFICATION OF SENESCENCE ALTERING THERAPEUTICS